Suliqua 100/50, solution injectable - 3 Swissmedic Key 66283001 Registration Holder Sanofi-Aventis (Suisse) SA Name Suliqua 100/50, solution injectable Date of registration 05.10.2017 Introduction of Sequence 05.10.2017 ATC-Classification Insulin Glargine and Lixisenatide (A10AE54) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06. Show package size 3 Index Therapeuticus (Swissmedic) 07.06. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 82.73 Limitation Yes Limitation text
Deductible 10 % Consumer price 106.40 Feedback FB Daily cost GTIN 7680662830011 Medication Code Biotechnologika Pharmacode 7298965 Disponibility
Composition insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 U., lixisenatidum 50 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. Packungsbestandteile Galenic Form Injektionslösung Excipiens Active Agent Dose Insulinum Glarginum 3.64 mg/ml correspond Insulinum Glarginum 100 U/ml Lixisenatidum 50 µg/ml
BAG: Active Agent Dose Insulinum Glarginum 100 U Lixisenatidum 50 mcg
Inactive agents Dose additional_information Glycerolum Metacresolum 2.7 mg/ml conserv. Methioninum Zinci Chloridum
Source Data was imported : 04.06.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
